Sharp corporate update, well appreciated.Key points :
- Having commercial units by November 2020 - Meaning that they must have insight on the potential approval of BioCloud???
- Potential customers and distribution partners - Already clients and sales in the pipeline, they can't publically talk about contracts or they have not signed yet a LOI.
- More monetary support from the Government? - Seems so, they are seeking support for commercialization funds, which is the next big step and a big win for investors.
- The company has a long history of sucess of CSA approvals, doesn't seem like a big stake.
Great news.
This is heading to 10$ before Xmas in my honest opinion.